Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.


Julian Peto FMedSci read maths at Oxford (1964-67) followed by an MSc in statistics at Imperial College. He worked as a statistician at Edinburgh University, then in London at the Institute of Psychiatry and the MRC TB Unit. He returned to Oxford in 1974 to join the ICRF Cancer Epidemiology and Clinical Trials Unit, part of Richard Doll’s burgeoning empire.

From 1983 to 2004 he was Cancer Research UK Professor of Epidemiology and head of the Section of Epidemiology at the Institute of Cancer Research where, together with Bruce Ponder and Mike Stratton, he initiated the work that led to the discovery of BRCA2.

His work has included clinical trials on various cancers and more recently the VIDAL (Vitamin D and Longevity) trial, and many epidemiological studies. His main current interests are the natural history of human papillomavirus infection and cervical cancer, particularly in relation to screening, and the hazards of asbestos, which were underestimated when he began studying it in 1975 and are now exaggerated.
His Chair was transferred to the London School of Hygiene and Tropical Medicine in 2004.

Forthcoming events

Richard Doll Seminar - Adventures in Digital Health Research: Alcohol, Coffee, and Arrhythmias

Tuesday, 03 September 2024, 1pm to 2pm @ Richard Doll Lecture Theatre, Richard Doll Building, OldRoad Campus, University of Oxford, OX3 7LF